Showing results (11-20 of 362) with videos related to
Sort By:
Pageof 37
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 25, 2020
Emerging intravesical therapies for the management of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer: Charting a path forwardAli Cyrus Chehroudi, Peter C BlackTranslational Cancer Research|February 4, 2022
Variant histology in bladder cancer: diagnostic and clinical implicationsAnna J Black, Peter C BlackTranslational Andrology and Urology|November 22, 2021
Combination therapies involving checkpoint-inhibitors for treatment of urothelial carcinoma: a narrative reviewGerald B Schulz, Peter C BlackCurrent Urology Reports|March 28, 2008
Growth factors and receptors as prognostic markers in urothelial carcinomaPeter C Black, Colin P N DinneyCurrent Opinion in Urology|February 9, 2026
The challenge of bladder preservation in muscle invasive bladder cancer: key concepts and future directionsMarie-Pier St-Laurent, Peter C BlackTherapeutic Advances in Medical Oncology|August 19, 2021
Novel and emerging approaches in the management of non-muscle invasive urothelial carcinomaOmid Yassaie, Cyrus Chehroudi, Peter C BlackNature Reviews. Urology|May 24, 2023
Urine biomarkers in bladder cancer - current status and future perspectivesMoritz Maas, Tilman Todenhöfer, Peter C BlackCancer Metastasis Reviews|August 30, 2007
Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trialPeter C Black, Colin P N DinneyUrologic Oncology|October 11, 2017
Routine bladder cancer treatment dictates divergence from trial-derived regimens: Results of treatment at 44 radiotherapy centersAnesa Ahamad, Alvaro Martinez, Sharon Salenius, et al.European Urology Oncology|July 8, 2019
Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?H Barton Grossman, Joaquim Bellmunt, Peter C BlackPageof 37